LC-0296, a novel SIRT3 inhibitor, can inhibit cell survival and promote apoptosis by increasing ROS levels in head and neck squamous cell carcinoma (HNSCC) cells (Alhazzazi et al., 2016). The gene discussed is SIRT3; the disease is head and neck squamous cell carcinoma.